[ad_1]
Brazil’s well being regulator Anvisa mentioned on Monday it had suspended scientific trials for China’s Sinovac coronavirus vaccine, due to a “severe adverse effect” that passed off on Oct. 29.
Anvisa didn’t present extra particulars, similar to whether or not the incident passed off in Brazil – the place trials are being carried out – or out of the country.
It additionally didn’t say why information of the October occasion was being communicated solely now.
[ad_2]
Source